Arrowhead Pharmaceuticals Inc.’s filing revealed that its Director Vakiener Victoria unloaded Company’s shares for reported $41935.0 on May 02 ’24. In the deal valued at $23.31 per share,1,799 shares were sold. As a result of this transaction, Vakiener Victoria now holds 30,205 shares worth roughly $0.72 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hamilton James C sold 6,000 shares, generating $168,180 in total proceeds. Upon selling the shares at $28.03, the Chief Discovery/Trans Medicine now owns 204,851 shares.
Before that, Lu Hongbo bought 1,000 shares. Arrowhead Pharmaceuticals Inc. shares valued at $27,500 were divested by the Director at a price of $27.50 per share. As a result of the transaction, Lu Hongbo now holds 33,680 shares, worth roughly $0.81 million.
Goldman initiated its Arrowhead Pharmaceuticals Inc. [ARWR] rating to a Neutral in a research note published on June 05, 2024; the price target was $31. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Citigroup began covering ARWR with “Neutral” recommendation on September 19, 2023. TD Cowen started covering the stock on July 21, 2023. It rated ARWR as “an Outperform”.
Price Performance Review of ARWR
On Friday, Arrowhead Pharmaceuticals Inc. [NASDAQ:ARWR] saw its stock fall -3.16% to $23.91. Over the last five days, the stock has gained 4.18%. Arrowhead Pharmaceuticals Inc. shares have fallen nearly -21.86% since the year began. Nevertheless, the stocks have fallen -34.42% over the past one year. While a 52-week high of $39.83 was reached on 01/10/24, a 52-week low of $20.67 was recorded on 04/25/24. SMA at 50 days reached $24.39, while 200 days put it at $27.86. A total of 1.05 million shares were traded, compared to the trading of 1.07 million shares in the previous session.
Levels Of Support And Resistance For ARWR Stock
The 24-hour chart illustrates a support level at 23.46, which if violated will result in even more drops to 23.01. On the upside, there is a resistance level at 24.35. A further resistance level may holdings at 24.79. The Relative Strength Index (RSI) on the 14-day chart is 47.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.29%. Stochastics %K at 60.52% indicates the stock is a holding.
